Cargando…
Vitiligo, From Physiopathology to Emerging Treatments: A Review
Vitiligo is a chronic inflammatory skin disease leading to the loss of epidermal melanocytes. To date, treatment options for vitiligo patients are limited, lack sustained efficacy, and are mainly based on off-label use of immunosuppressive agents, such as systemic or topical steroids or topical calc...
Autores principales: | Migayron, Laure, Boniface, Katia, Seneschal, Julien |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Healthcare
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7649199/ https://www.ncbi.nlm.nih.gov/pubmed/32949337 http://dx.doi.org/10.1007/s13555-020-00447-y |
Ejemplares similares
-
Targeting Innate Immunity to Combat Cutaneous Stress: The Vitiligo Perspective
por: Boniface, Katia, et al.
Publicado: (2021) -
Editorial: Immunology of Vitiligo
por: Seneschal, Julien, et al.
Publicado: (2021) -
Analysis of tumor response and clinical factors associated with vitiligo in patients receiving anti–programmed cell death-1 therapies for melanoma: A cross-sectional study
por: Dousset, Léa, et al.
Publicado: (2021) -
Etiopathogenesis and Emerging Methods for Treatment of Vitiligo
por: Iwanowski, Tomasz, et al.
Publicado: (2023) -
Renocardiac syndromes: physiopathology and treatment stratagems
por: Kingma, J. G., et al.
Publicado: (2015)